Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	150	206	193	124	408	341
Market Cap Growth	77.28%	6.70%	55.33%	-69.53%	19.67%	-56.07%
Enterprise Value	153	222	226	150	427	341
PE Ratio	9.69	9.54	96528.89	-4.27	-6.80	-4.51
PS Ratio	0.66	0.87	0.85	0.49	1.81	1.25
PB Ratio	2.93	3.85	8.94	-50.81	-68.55	19.52
P/FCF Ratio	4.22	7.67	-12.20	6.02	561.16	15.45
P/OCF Ratio	4.20	7.63	-12.20	6.02	527.77	15.24
EV/Sales Ratio	0.68	0.94	0.99	0.59	1.90	1.25
EV/EBITDA Ratio	3.69	4.66	10.34	-31.98	-11.95	-6.50
EV/EBIT Ratio	5.12	6.15	18.78	-9.38	-9.33	-5.63
EV/FCF Ratio	4.32	8.24	-14.30	7.26	586.90	15.43
Debt / Equity Ratio	2.17	2.09	5.29	-47.69	-20.32	6.88
Debt / EBITDA Ratio	2.67	2.35	5.22	-24.87	-3.39	-2.29
Debt / FCF Ratio	3.12	4.15	-7.22	5.65	166.37	5.45
Quick Ratio	1.34	1.45	1.57	1.13	1.12	1.64
Current Ratio	1.46	1.57	1.73	1.28	1.28	1.83
Asset Turnover	1.07	1.13	1.12	1.04	0.91	1.05
Interest Coverage	2.24	2.70	1.04	-1.25	-3.26	-4.03
Return on Equity (ROE)	35.40%	58.20%	0.00%	-358.10%	-909.80%	-302.70%
Return on Assets (ROA)	7.20%	10.40%	0.00%	-12.00%	-24.10%	-29.10%
Return on Capital (ROIC)	14.94%	18.84%	0.08%	1.13%	-26.44%	-28.36%
Earnings Yield	10.28%	10.48%	0.00%	-23.43%	-14.71%	-22.17%
FCF Yield	23.72%	13.04%	-8.20%	16.61%	0.18%	6.47%
Buyback Yield / Dilution	-2.19%	-5.83%	-10.56%	-2.69%	-2.08%	-2.18%
Total Shareholder Return	-2.19%	-5.83%	-10.56%	-2.69%	-2.08%	-2.18%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).